162 related articles for article (PubMed ID: 7200069)
21. Insulin-like growth factor-I (IGF-I) screening for the diagnosis of growth hormone (GH) deficiency.
Sriphrapradang A; Mahachoklertwattana P; Choubtum L; Preeyasombat C
J Med Assoc Thai; 1997 Jan; 80(1):51-5. PubMed ID: 9078817
[TBL] [Abstract][Full Text] [Related]
22. The use of growth hormone-releasing hormone in the diagnosis and treatment of short stature.
Grossman A; Savage MO; Blacklay A; Ross RM; Plowman PN; Preece MA; Coy DH; Besser GM
Horm Res; 1985; 22(1-2):52-7. PubMed ID: 2863206
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of insulin-like growth factor-1 and insulinlike growth factor binding protein-3 in diagnosis of growth hormone deficiency in short-stature children.
Ali A; Hashim R; Khan FA; Sattar A; Ijaz A; Manzoor SM; Younas M
J Ayub Med Coll Abbottabad; 2009; 21(3):40-5. PubMed ID: 20929010
[TBL] [Abstract][Full Text] [Related]
24. Use of insulin-like growth factor-binding protein-2 (IGFBP-2), IGFBP-3, and IGF-I for assessing growth hormone status in short children.
Smith WJ; Nam TJ; Underwood LE; Busby WH; Celnicker A; Clemmons DR
J Clin Endocrinol Metab; 1993 Nov; 77(5):1294-9. PubMed ID: 7521346
[TBL] [Abstract][Full Text] [Related]
25. Growth hormone release in response to human pancreatic tumor growth hormone-releasing hormone-40 in children with short stature.
Rogol AD; Blizzard RM; Johanson AJ; Furlanetto RW; Evans WS; Rivier J; Vale WW; Thorner MO
J Clin Endocrinol Metab; 1984 Oct; 59(4):580-6. PubMed ID: 6434572
[TBL] [Abstract][Full Text] [Related]
26. The use of a commercially available somatomedin-C radioimmunoassay in patients with disorders of growth.
Reiter EO; Lovinger RD
J Pediatr; 1981 Nov; 99(5):720-4. PubMed ID: 7197712
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of insulin-like growth factor I levels in predicting the response to provocative growth hormone testing.
Lee PD; Wilson DM; Rountree L; Hintz RL; Rosenfeld RG
Pediatr Res; 1990 Jan; 27(1):45-51. PubMed ID: 2296471
[TBL] [Abstract][Full Text] [Related]
28. [Somatomedin activity in patients with short stature due to hypopituitarism or constitutional-familial growth retardation].
Jasper HG; Martínez A; Heinrich JJ
Medicina (B Aires); 1983; 43(3):308-14. PubMed ID: 6672513
[No Abstract] [Full Text] [Related]
29. The usefulness of serum insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) for evaluation of children with short stature.
Jaruratanasirikul S; Leethanaporn K; Sriplung H
J Med Assoc Thai; 2000 Jun; 83(6):619-26. PubMed ID: 10932487
[TBL] [Abstract][Full Text] [Related]
30. Serum somatomedin A in growth retarded children.
Hizuka N; Takano K; Shizume K; Kawai K
Acta Endocrinol (Copenh); 1978 Aug; 88(4):625-32. PubMed ID: 210608
[TBL] [Abstract][Full Text] [Related]
31. Effects of pulsatile administration of growth hormone (GH)-releasing hormone on short term linear growth in children with GH deficiency.
Gelato MC; Ross JL; Malozowski S; Pescovitz OH; Skerda M; Cassorla F; Loriaux DL; Merriam GR
J Clin Endocrinol Metab; 1985 Sep; 61(3):444-50. PubMed ID: 3926806
[TBL] [Abstract][Full Text] [Related]
32. Somatostatin pretreatment enhances growth hormone (GH) responsiveness to GH-releasing hormone: a potential new diagnostic approach to GH deficiency.
Tzanela M; Guyda H; Van Vliet G; Tannenbaum GS
J Clin Endocrinol Metab; 1996 Jul; 81(7):2487-94. PubMed ID: 8675565
[TBL] [Abstract][Full Text] [Related]
33. Somatomedin-C in normal puberty and in true precocious puberty before and after treatment with a potent luteinizing hormone-releasing hormone agonist.
Harris DA; Van Vliet G; Egli CA; Grumbach MM; Kaplan SL; Styne DM; Vainsel M
J Clin Endocrinol Metab; 1985 Jul; 61(1):152-9. PubMed ID: 3889035
[TBL] [Abstract][Full Text] [Related]
34. Radioimmunological determination of somatomedin B in healthy children and in children with growth disturbances.
Wirth S; Schönberger W; Roth A; Grimm W
Acta Endocrinol (Copenh); 1983 Jan; 102(1):16-20. PubMed ID: 6823777
[TBL] [Abstract][Full Text] [Related]
35. Somatomedin-C and growth in children with precocious puberty: a study of the effect of the level of growth hormone secretion.
Rappaport R; Prevot C; Brauner R
J Clin Endocrinol Metab; 1987 Dec; 65(6):1112-7. PubMed ID: 3680478
[TBL] [Abstract][Full Text] [Related]
36. Changes in growth and serum growth hormone and plasma somatomedin-C levels during suppression of gonadal sex steroid secretion in girls with central precocious puberty.
Mansfield MJ; Rudlin CR; Crigler JF; Karol KA; Crawford JD; Boepple PA; Crowley WF
J Clin Endocrinol Metab; 1988 Jan; 66(1):3-9. PubMed ID: 2961786
[TBL] [Abstract][Full Text] [Related]
37. A new test for the diagnosis of growth hormone deficiency due to primary pituitary impairment: combined administration of pyridostigmine and growth hormone-releasing hormone.
Ghigo E; Imperiale E; Boffano GM; Mazza E; Bellone J; Arvat E; Procopio M; Goffi S; Barreca A; Chiabotto P
J Endocrinol Invest; 1990 Apr; 13(4):307-16. PubMed ID: 2115060
[TBL] [Abstract][Full Text] [Related]
38. Usefulness of growth hormone (GH) stimulation tests and IGF-I concentration measurement in GH deficiency diagnosis.
Obara-Moszyńska M; Kedzia A; Korman E; Niedziela M
J Pediatr Endocrinol Metab; 2008 Jun; 21(6):569-79. PubMed ID: 18717243
[TBL] [Abstract][Full Text] [Related]
39. Growth hormone (GH) and somatomedin c (SM-C) in Venezuelan boys.
Castro A; Castro S
J Trop Pediatr; 1988 Aug; 34(4):201-2. PubMed ID: 3172333
[No Abstract] [Full Text] [Related]
40. Clonidine accelerates growth in children with impaired growth hormone secretion.
Pintor C; Cella SG; Corda R; Locatelli V; Puggioni R; Loche S; Müller EE
Lancet; 1985 Jun; 1(8444):1482-5. PubMed ID: 2861413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
